J. C. Peng, S. Ardlie, K. G. Auclair, D. Bautista-piña, V. Duke et al., Sequence analysis of mutations and translocations across breast cancer subtypes, Nature, vol.486, pp.405-409

A. Bergamaschi, G. O. Hjortland, T. Triulzi, T. Sørlie, H. Johnsen et al., breast cancer xenograft models, Molecular Oncology, vol.22, issue.11, pp.469-482, 2009.
DOI : 10.1016/j.molonc.2009.07.003

H. Y. Chang, J. B. Sneddon, A. A. Alizadeh, R. Sood, R. B. West et al., Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds, PLoS Biology, vol.109, issue.2, p.7, 2004.
DOI : 10.1371/journal.pbio.0020007.sd002

J. Yee, J. A. Squire, P. W. Gout, S. Lam, and Y. Z. Wang, Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression-Related Changes, Clin Cancer Res, vol.12, pp.4043-4054, 2006.

Y. S. Derose, G. Wang, Y. Lin, P. S. Bernard, S. S. Buys et al., Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes, Nature Medicine, vol.302, issue.11, pp.1-8, 2011.
DOI : 10.1016/j.stem.2007.10.002

H. P. Dhakal, B. Naume, M. Synnestvedt, E. Borgen, R. Kaaresen et al., Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness, Histopathology, vol.28, issue.3, pp.350-364, 2012.
DOI : 10.1111/j.1365-2559.2012.04223.x

R. I. Fernando, M. D. Castillo, M. Litzinger, D. H. Hamilton, and C. Palena, IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells, Cancer Research, vol.71, issue.15, pp.5296-5306, 2011.
DOI : 10.1158/0008-5472.CAN-11-0156

H. H. Fiebig, A. Maier, and A. M. Burger, Clonogenic assay with established human tumour xenografts, European Journal of Cancer, vol.40, issue.6, pp.802-820, 2004.
DOI : 10.1016/j.ejca.2004.01.009

G. Gasparini, Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer, The Oncologist, vol.5, issue.90001, pp.37-44, 2000.
DOI : 10.1634/theoncologist.5-suppl_1-37

C. Ginestier, S. Liu, M. E. Diebel, H. Korkaya, M. Luo et al., CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts, Journal of Clinical Investigation, vol.120, issue.2, pp.485-497, 2010.
DOI : 10.1172/JCI39397DS1

URL : https://hal.archives-ouvertes.fr/hal-01431952

A. Gnirke, A. Melnikov, J. Maguire, P. Rogov, E. M. Leproust et al., Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing, Nature Biotechnology, vol.13, issue.2, pp.182-189, 2009.
DOI : 10.1038/nbt.1523

M. Guedj, L. Marisa, A. De-reynies, B. Orsetti, R. Schiappa et al., A refined molecular taxonomy of breast cancer, Oncogene, vol.10, issue.9, 2011.
DOI : 10.1038/nature09515

URL : https://hal.archives-ouvertes.fr/inserm-00611752

W. N. Hait, Anticancer drug development: the grand challenges, Nature Reviews Drug Discovery, vol.9, issue.4, pp.253-254, 2010.
DOI : 10.1038/nrd3144

Z. C. Hartman, G. M. Poage, . Hollander, P. Den, A. Tsimelzon et al., Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8, Growth of Triple- Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8, pp.3470-3480, 2013.
DOI : 10.1158/0008-5472.CAN-12-4524-T

Z. Hu, C. Fan, C. Livasy, X. He, D. S. Oh et al., A compact VEGF signature associated with distant metastases and poor outcomes, BMC Medicine, vol.68, issue.4, 2009.
DOI : 10.1158/0008-5472.CAN-07-2017

J. Kao, K. Salari, M. Bocanegra, Y. Choi, L. Girard et al., Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery, PLoS ONE, vol.4, issue.7, p.6146, 2009.
DOI : 10.1371/journal.pone.0006146.s003

M. D. Landis, B. D. Lehmann, J. A. Pietenpol, and J. C. Chang, Patient-derived breast tumor xenografts facilitating personalized cancer therapy, Breast Cancer Research, vol.11, issue.1, 2013.
DOI : 10.4137/CIN.S9983

E. Marangoni, A. Vincent-salomon, N. Auger, A. Degeorges, F. Assayag et al., A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays, Clinical Cancer Research, vol.13, issue.13, pp.3989-3998, 2007.
DOI : 10.1158/1078-0432.CCR-07-0078

R. M. Neve, K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, issue.6, pp.515-527, 2006.
DOI : 10.1016/j.ccr.2006.10.008

S. Nik-zainal, P. Van-loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman et al., The Life History of 21 Breast Cancers, Breast Cancer Working Group of the International Cancer Genome Consortium, pp.994-1007, 2012.
DOI : 10.1016/j.cell.2012.04.023

M. Nugoli, P. Chuchana, J. Vendrell, B. Orsetti, L. Ursule et al., Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications, BMC Cancer, vol.57, issue.1, 2003.
DOI : 10.1016/S0165-4608(99)00226-5

URL : https://hal.archives-ouvertes.fr/inserm-00115589

L. A. Petrillo, D. M. Wolf, A. M. Kapoun, N. J. Wang, A. Barczak et al., Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors, Breast Cancer Research and Treatment, vol.103, issue.8, pp.913-922, 2012.
DOI : 10.1007/s10549-012-2226-y

E. Quintana, M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson et al., Efficient tumour formation by single human melanoma cells, Nature, vol.24, issue.7222, pp.593-598, 2008.
DOI : 10.1038/nature07567

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597380

F. Reyal, C. Guyader, C. Decraene, C. Lucchesi, N. Auger et al., Molecular profiling of patient-derived breast cancer xenografts, Breast Cancer Research, vol.14, issue.1, p.11, 2012.
DOI : 10.1038/nm1764

URL : https://hal.archives-ouvertes.fr/inserm-00675301

A. Rody, T. Karn, C. Liedtke, L. Pusztai, E. Ruckhaeberle et al., A clinically relevant gene signature in triple negative and basal-like breast cancer, Breast Cancer Research, vol.54, issue.5, p.97, 2011.
DOI : 10.1002/jcb.240540406

C. Sotiriou, P. Wirapati, S. Loi, A. Harris, S. Fox et al., Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis, JNCI Journal of the National Cancer Institute, vol.98, issue.4, pp.262-272, 2006.
DOI : 10.1093/jnci/djj052

D. J. Waugh and C. Wilson, The Interleukin-8 Pathway in Cancer, Clinical Cancer Research, vol.14, issue.21, pp.6735-6741, 2008.
DOI : 10.1158/1078-0432.CCR-07-4843

X. Zhang, S. Claerhout, A. Prat, L. Dobrolecki, I. Petrovic et al., Patient-derived Human Breast Cancer Xenografts, Cancer Res